If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
373.60    1.80 (0.48%)
Bid:
373.20
Ask:
373.80
Spread: 0.60 (0.161%)
Market Cap: £1.98b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Hammerson Completes Refinancing Transactions

9 Oct 2024 07:00

RNS Number : 4219H
Hammerson PLC
09 October 2024
 

9 October 2024

Hammerson plc

("Hammerson" or the "Company/Group")

Hammerson completes refinancing transactions to underpin growth strategy

Following the successful issuance of its 12-year £400m bond, Hammerson sets out the final outcome of the new issuance and accompanying tender of the Company's outstanding bonds maturing in 2026 and 2028:

· 12-year £400m bond pricing confirmed on 3 October at a coupon of 5.875% representing a spread of 183 basis points over the reference gilt rate

· Strong demand led to peak order book in excess of £2.6bn (over 7x subscribed)

· The repurchase of a total of £411.6m bonds, comprising £168.4m of 6% 2026s and £243.2m of 7.25% 2028s

· An annualised net interest benefit to Hammerson of £3.6m1 per year (approximately £0.8m for the financial year ending 2024)

· This reduces weighted average gross interest from 3.8%2 to 3.6% and extends Hammerson's weighted average debt maturity from 2.9 years3 to 5.2 years

· The refinancing is largely leverage neutral; pro forma4 LTV at 30 June 2024 is 25.5% and net debt:EBITDA is 5.4x

 

Himanshu Raja, CFO of Hammerson plc, commented:

"The combined effect of our new £400m 5.875% bond maturing in 2036 and the tender of our existing short-dated sterling maturities reduces our ongoing interest costs and extends our weighted average debt maturity. The strong demand and competitive pricing are a clear recognition from investors of the strength of our portfolio, the robust balance sheet and the opportunity ahead of us."

 

1 Annualised interest benefit arises due to the weighted average interest cost on the bonds tendered (6% on 2026s and 7.87% on 2028s) being 7.1% and higher than the 5.875% coupon on the new issue, offset by the impact of new issue discounts and the reduction to interest receivable due to net cash outflows.

2 Weighted average gross interest rate at 30 June 2024 of 3.4% and pro forma for the refinancing of Dundrum in August 2024 of 3.8%.

3 Weighted average debt maturity at 30 June 2024 of 2.2 years and pro forma for the refinancing of Dundrum in August 2024 of 2.9 years. 

4 Pro forma for the tender and new issuance financing transactions and the disposal of the Group's interest in Value Retail generating net proceeds of £583m. Pro forma at 30 June 2024 reflecting only the disposal of the Group's interest in Value Retail; LTV was 24.7% and net debt:EBITDA was 5.3x.

 

ENDS

Hammerson plc

Investor Contact

Josh Warren, Hammerson, Director of Strategy, Commercial Finance and Investor Relations

 

 

 

+44 (0)20 7887 1053

MHP for Hammerson Media

Oliver Hughes

Ollie Hoare

 

+44 (0)7885 224 532

+44 (0)7817 458 804

 

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMGGKRNGDZM
Date   Source Headline
28th Jul 20227:01 amRNSDividend Declaration
28th Jul 20227:00 amRNSHalf-year Report
14th Jul 202212:15 pmRNSDirector/PDMR Shareholding
11th Jul 20221:00 pmRNSDirector/PDMR Shareholding
28th Jun 202210:45 amRNSNotice of Results
20th Jun 202212:00 pmRNSDirector/PDMR Shareholding
1st Jun 202210:00 amRNSBlock listing Interim Review
31st May 20224:50 pmRNSDirector/PDMR Shareholding
18th May 20224:30 pmRNSPurchase of Shares by the Employee Benefit Trust
17th May 202211:00 amRNSDirector/PDMR Shareholding
13th May 20224:50 pmRNSDirector/PDMR Shareholding
11th May 20224:30 pmRNSDirector/PDMR Shareholding
10th May 20224:30 pmRNSHolding(s) in Company
10th May 20229:00 amRNSTotal Voting Rights and Capital
5th May 20227:00 amRNSFinal Dividend and Enhanced Scrip Alternative
28th Apr 20224:15 pmRNSHolding(s) in Company
28th Apr 20223:30 pmRNSResult of AGM
26th Apr 20224:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202211:45 amRNSHolding(s) in Company
8th Apr 20223:30 pmRNSDirector/PDMR Shareholding
7th Apr 20221:00 pmRNSHolding(s) in Company
4th Apr 202211:00 amRNSHolding(s) in Company
1st Apr 202211:00 amRNSHolding(s) in Company
31st Mar 20221:00 pmRNSDirector Declaration
31st Mar 20229:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Mar 202212:00 pmRNSHolding(s) in Company
28th Mar 202211:30 amRNSHolding(s) in Company
24th Mar 202212:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20222:00 pmRNSAnnual Report, Notice of AGM and Scrip Circular
23rd Mar 202211:00 amRNSDirector/PDMR Shareholding
22nd Mar 20221:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20229:00 amRNSCurrency Conversion & Scrip Reference Share Price
18th Mar 202211:15 amRNSHolding(s) in Company
17th Mar 202211:00 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSCompletion of Silverburn disposal
15th Mar 20222:00 pmRNSHolding(s) in Company
14th Mar 20223:30 pmRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
4th Mar 20227:01 amRNSDividend Declaration
4th Mar 20227:01 amRNSDirectorate Change
4th Mar 20227:00 amRNSFinal Results
25th Feb 202211:30 amRNSDisposal of non-core assets
22nd Feb 20222:30 pmRNSDirectorate Change
21st Feb 202212:00 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSResponse to Press Speculation
15th Feb 202211:00 amRNSHolding(s) in Company
4th Feb 20229:00 amRNSNotification of 2021 Full Year Results
27th Jan 20227:00 amRNSTrading, operational and rent collection update
14th Jan 202211:15 amRNSHolding(s) in Company
13th Jan 20229:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.